Synapse - Ferrata Storti Foundation

Ferrata Storti Foundation

SHERPA: Unknown

People

Tallman
Levine
Zelenetz
Mauro
Stein
Abdel-Wahab
Dogan
Horwitz
Perales
Salles

Groups

Department of Medicine (295)
Hematologic Malignancies, Division of (294)
Center for Hematologic Malignancies (270)
Adult Leukemia (107)
Lymphoma (73)
GSK Faculty (70)
Executive Committee, Center for Hematologic Malignancies (60)
Hematologic Malignancies Research (45)
Sloan Kettering Institute Postdocs (43)
Center for Molecular Imaging and Biotechnology (CMIB) (41)

Search Within

Results (357)

Export to EndNote / Excel

Bosutinib vs imatinib for newly diagnosed chronic myeloid leukemia (BFORE Trial): 24-month efficacy update and results by 3-month BCR-ABL1 transcript levels

Meeting Abstract

Gambacorti-Passerini, C.; Brummendorf, T. H.; Abruzzese, E.; Rambaldi, A.; Ciceri, F.; Martino, B.; Hochhaus, A.; Deininger, M. W.; Mauro, M. J.; Chuah, C.; more...
Haematologica (2018)

Fulltext@MSK | Save

Long-term efficacy and cardiac, vascular and hypertension safety of bosutinib in previously treated patients with Philadelphia chromosome-positive leukemia

Meeting Abstract

Gambacorti-Passerini, C.; Brummendorf, T. H.; Kim, D. W.; Mauro, M. J.; Aguiar, J.; Viqueira, A.; Leip, E.; Cortes, J. E.
Haematologica (2018)

Fulltext@MSK | Save

Inhibidores de la isocitrato deshidrogenasa mutata (mIDH), ivosidenib o enasidenib, en combinación con azacitidina (AZA) en pacientes con leucemia mieloide aguda (LMA)

Meeting Abstract

Montesinos, P.; Di Nardo, C. D.; Stein, A. S.; Stein, E. M.; Fathi, A. T.; Schuh, A. C.; Odenike, O.; Kantarjian, H. M.; Stone, R. M.; Collins, R.; more...
Haematologica (2018)

Fulltext@MSK | Save

Phase 3 results for vosaroxin/cytarabine in the subset of patients ≥60 years old with refractory/early relapsed acute myeloid leukemia

Journal Article

Ravandi, F.; Ritchie, E. K.; Sayar, H.; Lancet, J. E.; Craig, M. D.; Vey, N.; Strickland, S. A.; Schiller, G. J.; Jabbour, E.; Pigneux, A.; more...
Haematologica (2018)

Fulltext@MSK | Save

Real-world treatment and outcomes among older adults with chronic lymphocytic leukemia before the novel agents era

Journal Article

Mato, A.; Jahnke, J.; Li, P.; Mehra, M.; Ladage, V. P.; Mahler, M.; Huntington, S.; Doshi, J. A.
Haematologica (2018)

Fulltext@MSK | Save

Impact of ibrutinib dose intensity on patient outcomes in previously treated Waldenström macroglobulinemia

Journal Article

Castillo, J. J.; Gustine, J. N.; Meid, K.; Dubeau, T. E.; Xu, L.; Yang, G.; Hunter, Z. R.; Advani, R.; Palomba, L.; Treon, S. P.
Haematologica (2018)

Fulltext@MSK | Save

Genomic characterization of spleens in patients with myelofibrosis

Journal Article

Zimran, E.; Tripodi, J.; Rampal, R.; Rappoport, F.; Zirkiev, S.; Hoffman, R.; Najfeld, V.
Haematologica (2018)

Fulltext@MSK | Save

Dramatically improved survival in multiple myeloma patients in the recent decade: Results from a Swedish population-based study

Journal Article

Thorsteinsdottir, S.; Dickman, P. W.; Landgren, O.; Blimark, C.; Hultcrantz, M.; Turesson, I.; Björkholm, M.; Kristinsson, S. Y.
Haematologica (2018)

Fulltext@MSK | Save

Real-world outcomes and management strategies for venetoclax-treated chronic lymphocytic leukemia patients in the United States

Journal Article

Mato, A. R.; Thompson, M.; Allan, J. N.; Brander, D. M.; Pagel, J. M.; Ujjani, C. S.; Hill, B. T.; Lamanna, N.; Lansigan, F.; Jacobs, R.; more...
Haematologica (2018)

Fulltext@MSK | Save

Impact of age on genetics and treatment efficacy in follicular lymphoma

Journal Article

Alig, S.; Jurinovic, V.; Pastore, A.; Bararia, D.; Häbe, S.; Hellmuth, J. C.; Kridel, R.; Gascoyne, R.; Schmidt, C.; Zöllner, A. K.; more...
Haematologica (2018)

Fulltext@MSK | Save

Ferrata Storti Foundation – authorized name for:

Ferrata Storti Foundation